Related references
Note: Only part of the references are listed.Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to other systemic inflammatory response markers in non-small cell lung cancer
Qing Huang et al.
MEDICINE (2020)
Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer
Yuki Katayama et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer
Xue Yan et al.
BIOSCIENCE REPORTS (2020)
Serum markers associated with treatment response and survival in non-small cell lung cancer patients treated with anti-PD-1 therapy
Kazuki Takada et al.
LUNG CANCER (2020)
Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening
Robert A. Smith et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Monocyte heterogeneity and functions in cancer
Claire E. Olingy et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
The innate immune architecture of lung tumors and its implication in disease progression
Simon Milette et al.
JOURNAL OF PATHOLOGY (2019)
Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients
Xu-Chao Zhang et al.
NATURE COMMUNICATIONS (2019)
Prognostic value of a novel scoring system using inflammatory response biomarkers in non-small cell lung cancer: A retrospective study
Yan Wang et al.
THORACIC CANCER (2019)
Prognostic value of delta inflammatory biomarker-based nomograms in patients with inoperable locally advanced NSCLC
Meiying Guo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Tertiary lymphoid structures in the era of cancer immunotherapy
Catherine Sautes-Fridman et al.
NATURE REVIEWS CANCER (2019)
Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
Max D. Wellenstein et al.
IMMUNITY (2018)
Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion
Jeong Uk Lim et al.
PLOS ONE (2018)
Systemic Inflammation Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single Center Experience
Hui Luo et al.
JOURNAL OF CANCER (2018)
The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs
Yuan Zhang et al.
MEDICINE (2018)
Mean platelet volume and lymphocyte-to-monocyte ratio are associated with shorter progression-free survival in EGFR-mutant lung adenocarcinoma treated by EGFR tyrosine kinase inhibitor
Kousuke Watanabe et al.
PLOS ONE (2018)
Prognostic impact of pretreatment lymphocyte-to-monocyte ratio in advanced epithelial cancers: a meta-analysis
Yiming Mao et al.
CANCER CELL INTERNATIONAL (2018)
Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation
Seigo Minami et al.
WORLD JOURNAL OF ONCOLOGY (2018)
Cancer and inflammation
Lance L. Munn
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2017)
Preoperative pulmonary function correlates with systemic inflammatory response and prognosis in patients with non-small cell lung cancer: results of a single-institution retrospective study
Yongyin Gao et al.
ONCOTARGET (2017)
Selected patients can benefit more from the management of etoposide and platinum-based chemotherapy and thoracic irradiation-a retrospective analysis of 707 small cell lung cancer patients
Shoubo Cao et al.
ONCOTARGET (2017)
Preoperative platelet to lymphocyte and neutrophil to lymphocyte ratios are independent prognostic factors for patients undergoing lung cancer radical surgery: A single institutional cohort study
Haidan Lan et al.
ONCOTARGET (2017)
Prognostic value of pretreatment inflammatory biomarkers in advanced lung adenocarcinoma patients receiving first-line pemetrexed/platinum doublet
Yanjuan Xiong et al.
TUMOR BIOLOGY (2017)
The lymphocyte-monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy
Xuemei Liu et al.
ONCOTARGETS AND THERAPY (2017)
Combination of platelet count and lymphocyte to monocyte ratio is a prognostic factor in patients undergoing surgery for non-small cell lung cancer
Wei Liu et al.
ONCOTARGET (2017)
Does lymphocyte-to-monocyte ratio before, during, or after definitive chemoradiation for locally advanced pancreatic cancer predict for clinical outcomes?
Irene Giacomelli et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2017)
Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies
Zubing Mei et al.
CANCER TREATMENT REVIEWS (2017)
Lymphocyte to monocyte ratio is associated with response to first-line platinum-based chemotherapy and prognosis of early-stage non-small cell lung cancer patients
Ying-Jian Song et al.
TUMOR BIOLOGY (2016)
Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer
Mehmet Kos et al.
WIENER KLINISCHE WOCHENSCHRIFT (2016)
Prognostic Significance of the Preoperative Lymphocyte to Monocyte Ratio in Patients With Stage I Non-Small Cell Lung Cancer Undergoing Complete Resection
Honggang Xia et al.
CANCER INVESTIGATION (2016)
Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus
Yunxiu Wu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development
Pablo Sanchez-Salcedo et al.
LUNG CANCER (2016)
Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer
Xin Wang et al.
ONCOTARGETS AND THERAPY (2016)
Prognostic value of the lymphocyte-to-monocyte ratio and other inflammatory markers in malignant pleural mesothelioma
Abdullah Cetin Tanrikulu et al.
ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE (2016)
Cancer-related inflammation and treatment effectiveness
Connie I. Diakos et al.
LANCET ONCOLOGY (2014)
Prognostic impact of circulating monocytes and lymphocyte-to-monocyte ratio on previously untreated metastatic non-small cell lung cancer patients receiving platinum-based doublet
Gui-Nan Lin et al.
MEDICAL ONCOLOGY (2014)
Prognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancer
Se-Il Go et al.
MEDICAL ONCOLOGY (2014)
Prognostic Significance of Systemic Inflammation-Based Lymphocyte- Monocyte Ratio in Patients with Lung Cancer: Based on a Large Cohort Study
Pingping Hu et al.
PLOS ONE (2014)
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma
Luis F. Porrata et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Share Paper
